NASDAQ:ANTX | Free Cash Flow | AN2 Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2021-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$12.07M
2025-12-31-$5.24M
2025-03-31-$10.62M
2024-12-31-$5.27M
2024-03-31-$17.59M
2023-12-31-$17.07M
2023-03-31-$11.6M
2022-12-31-$7.64M
2022-03-31-$6.74M
2021-12-31-$8.99M
2021-03-31-$1.54M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$29.83M
2024-12-31-$49.26M
2023-12-31-$53.29M
2022-12-31-$33.46M
2021-12-31-$20.48M